A new study finds that combining the current medications for Alzheimer’s disease with small molecules derived from micronutrients found in grapes, berries, peanuts and turmeric is a safer and more effective way to treat the disease.

UAB researchers discover the mechanism by which neurofibrillary tangles spread through the brain of Alzheimer’s patients is via connected neurons, and these findings reveal a major disease etiology that could lead to new therapies that slow Alzheimer’s disease progression.

A UAB research team defines the criteria these immunotherapies must meet to advance both conceptually and in trials, which are still at a very preliminary stage

They should have high selective precision and be programmable, sustained over time, and controllable throughout the pathologies. Macrophages, microglia and regulatory T cells would be appropriate effector cells for these treatments